Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase Ib Trial of Concurrent Cetuximab (ERBITUX®) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY®) in Locally Advanced Head and Neck Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01935921
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:06.766583+00:00
Published At
2023-06-15T00:00:00+00:00
Record Updated At
2023-06-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7", "Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7", "Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7", "Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7", "Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-15"
protocolSection.identificationModule.nctId
"NCT01935921"
protocolSection.identificationModule.officialTitle
"A Phase Ib Trial of Concurrent Cetuximab (ERBITUX\u00ae) and Intensity Modulated Radiotherapy (IMRT) With Ipilimumab (YERVOY\u00ae) in Locally Advanced Head and Neck Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.